Target intelligence / Profile preview

Cysteine-rich hydrophobic domain-containing protein 2 (CHIC2)

Target
CHIC2
Molecular classification
Other (Palmitoylated, membrane-associated small protein), Not a known member of established receptor, enzyme, transporter, or ion channel superfamilies, CHIC family
01

Overview

Cysteine-rich hydrophobic domain-containing protein 2 (CHIC2) is a small, palmitoylated membrane-associated protein found predominantly in vesicular structures and the plasma membrane. It belongs to the CHIC family and is characterized by a conserved cysteine-rich hydrophobic motif. While CHIC2 itself has not been shown to be a direct therapeutic target, its deletion in chromosome 4q12 serves as a critical diagnostic marker: it indicates the presence of the oncogenic FIP1L1–PDGFRA fusion in myeloproliferative neoplasms and mastocytosis, predicting response to tyrosine kinase inhibitors like imatinib. CHIC2 is also occasionally seen as a fusion partner with ETV6 in rare leukemia subtypes and may have other disease associations through its mRNA regulatory roles or gene dosage effects in glioblastoma and migraine. If you intend to retrieve structured target data for drug development or molecular pharmacology, CHIC2’s primary value is as a diagnostic biomarker and genetic marker for therapy selection, not as a classical drug target.

Other names
BTLBrX-like translocated in leukemiaCysteine-rich hydrophobic domain 2 proteinCysteine-Rich Hydrophobic Domain-Containing Protein 2Cystein-Rich Hydrophobic Domain 2
02

Mechanism of action

Not applicable for CHIC2 directly; for FIP1L1–PDGFRA, inhibition of tyrosine kinase activity (by imatinib)

03

Biological functions

Associated with vesicular structures and plasma membraneMay play a role in mRNA stability and regulation in response to stress (e.g., nitric oxide)Noted as a fusion partner in certain leukemiasServes predominantly as a genomic marker for specific gene fusions (notably FIP1L1–PDGFRA)
04

Disease associations

Cancer (acute myeloid leukemia, glioblastoma, systemic mastocytosis, hypereosinophilic syndrome, other hematologic malignancies)Migraine (lower protein levels possibly causally associated with risk)Other disease roles primarily indirect via association with chromosomal rearrangements
05

Safety considerations

None directly associated with CHIC2 as a therapeutic target; the main clinical concern is proper interpretation of genetic testing for guiding imatinib therapy
06

Interacting drugs

No drugs directly target CHIC2

1 more in the full profile.

07

Biomarkers

CHIC2 locus deletion (used as a surrogate marker for FIP1L1–PDGFRA gene fusion in myeloproliferative disorders and systemic mastocytosis)

Beyond the preview

Go deeper on Cysteine-rich hydrophobic domain-containing protein 2 (CHIC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cysteine-rich hydrophobic domain-containing protein 2 (CHIC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call